Morneau Shepell

PIC Group is an independent provider of turnkey services and programs. Its programs are focused on power generation, pulp and paper, refinery and other industrial facilities. The company acts as a third-party provider of staffing, maintenance, software, asset management and software solutions. Headquartered outside of downtown Atlanta in Marietta, Ga., PIC operates more than 20 facilities worldwide. PIC serves United States clients with offices in Georgia and Texas and internationally from offices in Argentina, Brazil, Lebanon, Malaysia, Mexico and Switzerland.

UCB Pharma is one of many wholly-owned subsidiaries of UCB S.A., a biopharmaceutical leader specializing in fields of central nervous system disorders, allergy and respiratory diseases, immune and inflammatory disorders and oncology. The company s main products include Keppra, Xyzal, Nootropil, Atarax, Lortab, Tussionex, Metadate CD, Equasym XL and Dipentum. The company directs profits from the sale and distribution of its products toward further research in its many fields. UCB Pharma s parent company maintains numerous additional facilities worldwide. The company recently acquired Celltech Group, helping form one of the world s largest biopharmaceutical companies. UCB was founded in 1928 by Emmanuel Janssen, a far-sighted Belgian businessman. UCB Pharma maintains its headquarters in Smyrna, Ga.